Alps Advisors Inc Paratek Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$4.8 - $11.6 $269,515 - $651,328	-56,149 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$9.05 - $10.95 $93,178 - $112,741	10,296 Added 22.45%	56,149 $545,000
Q2 2018 Aug 02, 2018	BUY	$10.2 - $13.9 $151,898 - $206,998	14,892 Added 48.1%	45,853 $468,000
Q2 2018 Jul 25, 2018	SELL	$10.2 - $13.9 $109,609 - $149,369	-10,746 Reduced 25.77%	30,961 $554,000
Q1 2018 May 01, 2018	BUY	$12.65 - $18.85 $135,936 - $202,562	10,746 Added 34.71%	41,707 $542,000
Q4 2017 Feb 05, 2018	BUY	$17.45 - $25.6 $63,203 - $92,723	3,622 Added 13.25%	30,961 $554,000
Q3 2017 Nov 03, 2017	BUY	$18.9 - $28.2 $516,707 - $770,959	27,339	27,339 $686,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.